Journey Medical Corporation
10 clinical trials · Sponsor
◉ Watch Journey Medical Corporation
| Record | Firm | Date |
|---|---|---|
| Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks (NCT05597462) | Journey Medical Corporation | 2022-09-30 |
| A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects (NCT05452785) | Journey Medical Corporation | 2022-05-07 |
| A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) (NCT05343455) | Journey Medical Corporation | 2022-03-29 |
| A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. (NCT05296629) | Journey Medical Corporation | 2022-03-14 |
| A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis (NCT03880266) | Journey Medical Corporation | 2019-02-22 |
Track Journey Medical Corporation automatically
Every clearance here is in the API, with alerts when new ones post.